Furthermore, both ELF4 and ETV6 expressions are downregulated at grade 2 glioma, but upregulated at increasing levels in grades 3 and 4, indicating that these genes can also be utilized as additional molecular determinants to distinguish glioma grades. Here, ELF4 is linked to central nervous system cancer.